Literature DB >> 8101289

Acute encephalopathy with vigabatrin.

A Sälke-Kellermann, H Baier, B Rambeck, H E Boenigk, P Wolf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8101289     DOI： 10.1016/0140-6736(93)91397-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Rapid aggravation of aphasia by vigabatrin.

Authors:  R Gil; J P Neau
Journal:  J Neurol       Date:  1995-03       Impact factor: 4.849

Review 2.  Adverse reactions to new anticonvulsant drugs.

Authors:  I C Wong; S D Lhatoo
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

Review 3.  The safety and tolerability of newer antiepileptic drugs in children and adolescents.

Authors:  Dean P Sarco; Blaise F D Bourgeois
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

4.  Seizures in a boy with succinic semialdehyde dehydrogenase deficiency treated with vigabatrin (gamma-vinyl-GABA).

Authors:  D Matern; W Lehnert; K M Gibson; R Korinthenberg
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.